OpenCell Technologies Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 5


  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.13M

  • Investors
  • 6

OpenCell Technologies General Information


Developer of a cell and gene therapy platform designed to commercialize cell-based analysis techniques and discover new cancer therapies. The company's platform offers high-throughput, and scalable transfection tools to the life science industry, enabling researchers to use difficult-to-transect cells like primary and cancer stem cell cultures and discover new therapeutic cell-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Corporate Office
  • CORTEX BioScience District, 4340 Duncan Avenue
  • BioGenerator, Suite 218
  • Saint Louis, MO 63110
  • United States
+1 (404) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OpenCell Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2021 $1.13M 00000 Completed Generating Revenue
5. Accelerator/Incubator 00000 Completed Generating Revenue
4. Grant 01-Sep-2019 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series A) 16-Mar-2015 00000 00000 00.000 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. Grant 01-Jan-2014 $2.41M Completed Startup
To view OpenCell Technologies’s complete valuation and funding history, request access »

OpenCell Technologies Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000 00.000000 00.00 00.00 00 00.00 00.000
To view OpenCell Technologies’s complete cap table history, request access »

OpenCell Technologies Executive Team (6)

Name Title Board Seat Contact Info
Levent Degertekin Ph.D Co-Founder
Mark Meacham Ph.D Co-Founder
Chad Stiening Executive Chairman
Andrei Fedorov Ph.D Co-Founder, President & Board Member
Paul Olivo Ph.D Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

OpenCell Technologies Board Members (4)

Name Representing Role Since
Andrei Fedorov Ph.D Self Co-Founder, President & Board Member 000 0000
Behzad Mahdavi Ph.D OpenCell Technologies Board Member 000 0000
Chad Stiening OpenCell Technologies Executive Chairman 000 0000
Charles Bolten BioGenerator Ventures Board Member 000 0000
To view OpenCell Technologies’s complete board members history, request access »

OpenCell Technologies Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OpenCell Technologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
BioGenerator Ventures Venture Capital Minority 000 0000 000000 0
Synchrony Bio Venture Capital Minority 000 0000 000000 0
National Center for Research Resources Government 000 0000 000000 0
National Institute of General Medical Sciences Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

OpenCell Technologies FAQs

  • When was OpenCell Technologies founded?

    OpenCell Technologies was founded in 2008.

  • Who is the founder of OpenCell Technologies?

    Levent Degertekin Ph.D, Mark Meacham Ph.D, and Andrei Fedorov Ph.D are the founders of OpenCell Technologies.

  • Where is OpenCell Technologies headquartered?

    OpenCell Technologies is headquartered in Saint Louis, MO.

  • What is the size of OpenCell Technologies?

    OpenCell Technologies has 5 total employees.

  • What industry is OpenCell Technologies in?

    OpenCell Technologies’s primary industry is Biotechnology.

  • Is OpenCell Technologies a private or public company?

    OpenCell Technologies is a Private company.

  • What is OpenCell Technologies’s current revenue?

    The current revenue for OpenCell Technologies is 000000.

  • How much funding has OpenCell Technologies raised over time?

    OpenCell Technologies has raised $344K.

  • Who are OpenCell Technologies’s investors?

    U.S. Department of Health and Human Services, BioGenerator Ventures, Synchrony Bio, National Center for Research Resources, and National Institute of General Medical Sciences are 5 of 6 investors who have invested in OpenCell Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »